Moleculin Biotech Inc

Moleculin Biotech Inc is a clinical-stage pharmaceutical company focused on discovering and developing novel therapies. The US-based company aims to address various cancers, including acute myeloid leukaemia and pancreatic cancer, along with other difficult-to-treat diseases, through targeted approaches. Operating within the biopharmaceutical sector, Moleculin Biotech Inc specialises in developing anti-cancer and anti-viral drug candidates. Its approach involves targeting critical pathways within diseased cells. The company's research aims to provide new treatment options for patients with significant unmet medical needs, enhancing therapeutic outcomes. Keep up to date on the latest share price by adding MBRX stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.